Sunday, April 13, 2025

Technology | 2018.09.12

Targovax Announces Publication of New Oncolytic Virus Data in the Journal of Medical Virology and Cancer Gene Therapy

OSLO, Norway, Sept. 12, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, is pleased to note that pre-clinical data from its ONCOS oncolytic virus program has been published in two...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]er-gene-therapy-300710957.html

You need to login to post comments.

Feed last updated 2025/04/30 @8:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News